GE HealthCare Technologies Inc.

“GE HealthCare's operations are organized and managed through four reportable segments: Imaging, Advanced Visualization Solutions ("AVS"), Patient Care Solutions ("PCS"), and Pharmaceutical Diagnostics ("PDx")”

“Sales of services increased 5.6% or $368 million primarily driven by growth in new and existing customer contractual agreements.”

“United States and Canada ("USCAN") $9,531$8,9816.1% Europe, the Middle East, and Africa ("EMEA") 5,4255,0517.4% China region 2,2512,360(4.6)% Rest of World 3,4183,2804.2%”

“We generate the majority of our revenue outside of the U.S. and our business is sensitive to global economic conditions.”

“Imaging $9,245$8,8554.4%3.8% AVS 5,3545,1314.3%3.8% PCS 3,0863,125(1.2)%(1.5)% PDx 2,9002,50815.6%8.8%”

“We had $214 million and $162 million of assets in, or directly related to, Russia and Ukraine as of December 31, 2025 and December 31, 2024, respectively, none of which are subject to sanctions that impact the carrying value of the assets. We generated revenues of $353 million and $363 million from customers in these two countries”

“Supply chain interruptions or price increases in certain key countries, such as China, India, Russia, and Israel, have had, and could continue to have, a similar adverse effect on our business.”

“We rely upon supplies of certain raw materials, including helium, iodine, and rare earth minerals.”

“We rely upon supplies of certain raw materials including helium, iodine, and rare earth minerals.”

“Such principal currencies include the Euro, the Chinese Renminbi, the Japanese Yen, the Norwegian Krone, and the British Pound Sterling, among others.”

“The potential increase in fair value of our foreign currency derivative contracts from a 10% decrease in USD spot rates against other applicable currencies would have been $111 million as of December 31, 2025.”

“As of the year ended December 31, 2025, our largest currency exposures are the Euro, Chinese Renminbi, Japanese Yen, Norwegian Krone, and British Pound Sterling.”

“we rely on contract manufacturing organizations to produce certain of our molecular imaging pharmaceutical products.”

“PDx segment revenues were $2,900 million, growing 15.6% or $392 million as reported, driven by an increase in Organic revenue* and the acquisition of Nihon Medi-Physics Co., Ltd. ("NMP").”

“Our business strategy includes substantial investment in R&D, with a focus on AI, cloud, edge computing, and software offerings.”

“The costs of certain raw materials, logistics, and services necessary for the production and distribution of our products are subject to fluctuation”

“we have $9,500 million outstanding principal of fixed-rate senior unsecured notes and $500 million outstanding principal on the Term Loan Facility which carries a variable interest rate”

“we executed an aggregate notional amount of interest rate swap contracts to synthetically convert $2,700 million of our senior unsecured notes from fixed rates to variable rates”

“increased competition from local companies and the prevalence of Volume Based Procurement policies, both of which have impacted our orders and revenues”

“tariffs materially impacted our Operating income by approximately $245 million and cash flows by approximately $285 million for the year ended December 31, 2025, primarily the bilateral U.S. and Chinese tariffs and U.S. tariffs on all other global import suppliers”

“On July 4, 2025, the One Big Beautiful Bill Act was signed into U.S. law, which includes significant changes to the federal income tax system. The changes did not have a material impact to the Company's tax provision for the year ended December 31, 2025.”

“the U.S. False Claims Act (the "FCA") imposes civil liability on any person or entity that submits, or causes the submission of, a false or fraudulent claim to the U.S. government.”

“U.S. regulators have adopted regulations that prohibit or restrict certain transfers of bulk U.S. sensitive personal data or U.S. government-related data to specified countries of concern”

“in 2025, China significantly tightened its export controls on rare earth minerals. Some, but not all, of these restrictions were temporarily suspended after trade negotiations with the U.S. in October 2025.”

“tariffs materially impacted our profitability and cash flows in 2025, primarily the bilateral U.S. and Chinese tariffs and U.S. tariffs on all other global import suppliers”

“Healthcare markets are characterized by rapidly evolving technology, frequent introduction of new products, intense competition, and pricing pressures.”

“In 2023, China's Central Commission for Discipline Inspection, the National Supervisory Commission, and other governmental entities in China initiated an anti-corruption campaign focused on the healthcare sector, which contributed to delayed orders and sales in our China business.”

“Our IT systems have been subject to computer malware, unauthorized access, and other cyber-attacks.”

“If the costs of certain commodities or of energy, shipping, or transportation increase and we are unable to pass along these costs to our customers, our financial results would be adversely affected.”

“We review our long-lived assets, including identifiable intangible assets, goodwill, and property, plant, and equipment ("PP&E"), for impairment at least annually.”

“the Librarian of Congress in the U.S. has authorized a copyright act exemption that allows third-party repair companies to circumvent OEM copyright protections on software in its medical imaging device or system”

“Our inability to manage our supply chain or obtain supplies of components or raw materials... has restricted, and could continue to restrict, the manufacturing of products, cause delays in delivery”

“We continue to have exposure to such risks to the extent they are not hedged.”

“Our business could be adversely affected by increased cybersecurity requirements, vulnerabilities, threats, and more sophisticated and targeted cybercrimes”

“during 2025, the U.S. imposed a variety of new tariffs on most imports from all countries in the world. This in turn prompted several countries to announce tariffs on U.S. imports.”

“Disruptions in deliveries, capacity constraints, production disruptions up- or down-stream, price increases, or decreased availability of raw materials or commodities (including as a result of war, natural disasters, climate change-related physical and transitional risks, actual or threatened public health emergencies, or other business continuity events)”

“Efforts by public and private payers to control the growth of healthcare costs may affect the price of and demand for our products and services.”

“We rely on software, SaaS, hardware, and other material components from a number of third parties to manufacture our products or otherwise operate our business.”

“We rely on third-party transport and warehouse management services for reliable and secure point-to-point transportation of our products to our customers and patients”

“We are subject to antitrust and competition laws, which generally prohibit certain types of conduct deemed to be anti-competitive”

“we may be compelled to take additional measures to preserve our cash flow, including through the reduction of operating expenses or suspension of dividend payments”

“the industry shifting away from traditional healthcare venues like hospitals and toward clinics, physician offices, and patients' homes”

“Our existing indebtedness, and any additional indebtedness that we may incur, could have important consequences for our business.”

“The implementation of localization requirements and the other government policies in certain geographies such as China and Russia creates a risk that, if we do not localize our products or operations to meet such requirements, we could lose market share”

“The impact of these risks is heightened if our production capacity is at or near full utilization (or if we lack alternative manufacturing sites)”

“the Russia and Ukraine conflict”